Treatment
Treatment A clinical trials
We’re tracking 8,322 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT07047365RecruitingPhase 3
New drug for HER2-positive advanced breast cancer
This trial tests a new medicine called TQB2930 for people with advanced breast cancer that is HER2-positive. It is for those who have already had at least two prior anti-HER2 treatments and are willing to also receive chemotherapy chosen by their doctor.
Bengbu, AnhuiAges 18–75 - NCT07047690RecruitingPhase 2
Nemolizumab for adults with scleroderma
This study tests an investigational drug called nemolizumab for adults with systemic sclerosis (scleroderma). It aims to see if the drug can help reduce skin thickening and other symptoms, especially in people with early or moderate disease.
Ann Arbor, MichiganAges 18 years+ - NCT07054190RecruitingPhase 2
Testing inavolisib for early-stage PIK3CA-mutated breast cancer
This study tests a new drug called inavolisib for people with early-stage breast cancer that has a specific genetic change (PIK3CA mutation). The goal is to see if adding this drug to standard hormone therapy is safe and effective before surgery.
Los Angeles, CaliforniaAges 18 years+ - NCT07048808RecruitingPhase 2
Gene therapy for chronic chest pain
This trial tests a new gene therapy (XC001) delivered through a thin tube into your heart's blood vessels. It aims to grow new blood vessels to relieve chest pain in people with chronic angina who have no other treatment options.
Birmingham, AlabamaAges 18–85 - NCT06989450Recruiting
Digital support for women on hormone therapy for breast cancer
This trial tests a smartphone app called Sidekick to help women with early-stage breast cancer stick to their hormone therapy and feel more confident managing their health. If you were diagnosed with stage I, II, or III breast cancer after September 2023 and are starting hormone therapy, this program might help you stay on track.
ReykjavikAges 18 years+ - NCT06991946Recruiting
Genomic profiling for metastatic breast cancer in Spain
This study looks at how genetic testing of your tumor might affect the treatment plan for your metastatic breast cancer. It aims to help doctors choose the best therapy based on your tumor's profile.
Barcelona, BarcelonaAges 18 years+ - NCT07046884Recruiting
Personalized Cancer Treatment Decisions Study
This study tests a new way to help you and your doctor choose the best cancer treatment together. If you are 18 or older, in a participating hospital's oncology program, and have not yet made a treatment decision, this trial may be a good fit.
GroningenAges 18 years+ - NCT07047014RecruitingPhase 3
Tenecteplase for medium vessel occlusion stroke (ARTS trial)
This trial tests the clot-busting drug tenecteplase in people who had a stroke 4.5 to 24 hours ago due to a medium-sized artery blockage. It aims to see if this medication can improve outcomes without needing a procedure to remove the clot.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07047560RecruitingPhase 2
A new chemo combo for advanced colorectal cancer
This trial tests a different way of giving a chemotherapy drug called irinotecan, along with two other drugs (5-FU and bevacizumab), for people whose cancer got worse after first-line treatment. It aims to see if this combination can help control the cancer.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07046078RecruitingPhase 2
Chemo, radiation, and donor transplant for older adults with high-risk AML
This trial tests a combination of chemotherapy (FLAG-Ida) followed by low-dose total body radiation and a stem cell transplant from a donor. It is for people age 60 and older with newly diagnosed high-risk blood cancers, aiming to improve outcomes with a less intense transplant preparative regimen.
Seattle, WashingtonAges 18 years+ - NCT07045935RecruitingPhase 4
Metabolic effects of cabergoline in prolactinoma patients
This study looks at metabolic health (like blood sugar and cholesterol) in people with prolactinomas who are being treated with the drug cabergoline. It aims to understand how lowering prolactin affects the body's metabolism and may help guide better care for patients with this condition.
BaselAges 18 years+ - NCT07052175Recruiting
Preventing relapse in behavioral disorders with a smartphone app
This study tests whether a smartphone app can help prevent relapse in people with behavioral disorders. If you speak Spanish, have a smartphone, and are willing to use the app, you may be able to join.
Ciempozuelos, MadridAges 18–90 - NCT07048366Recruiting
Mindfulness in a museum for fibromyalgia pain relief
This study tests whether a mindfulness program held in a museum setting can help women with fibromyalgia feel less pain and improve their quality of life. You would attend sessions in a museum and practice mindfulness techniques.
Chieti, AbruzzoAges 18–60 - NCT07053254Recruiting
Studying vein grafts in older heart bypass patients
This trial looks at how vein grafts work in older adults who need coronary artery bypass surgery. It aims to understand why grafts sometimes fail, so doctors can improve treatment.
SeoulAges 19–100 - NCT07050940Recruiting
Adding a gut supplement to immunotherapy for advanced melanoma
This trial tests whether adding a postbiotic (a gut-health supplement) to a standard immunotherapy called anti-PD-1 makes it work better for people with advanced melanoma that hasn't been treated yet. It may help shrink tumors or slow the cancer's growth.
Bari, BAAges 18 years+ - NCT07045155RecruitingPhase 4
Study of pegmolesatide for anemia in dialysis patients
This trial tests a new medication, pegmolesatide, to treat anemia in people who have been on dialysis for at least three months. It aims to help improve red blood cell levels without needing as many other anemia treatments.
Beijing, Beijing MunicipalityAges 18–80 - NCT07051694Recruiting
Ear nerve stimulation for sepsis patients in the ICU
This trial tests a non-invasive ear stimulation device (taVNS) as an extra treatment for sepsis in the ICU. It may help reduce inflammation and improve recovery.
ChongqingAges 18–80 - NCT07045857Recruiting
H. pylori recurrence: causes and patterns
This study looks at whether H. pylori infection comes back after treatment and what factors might cause it to come back. It is for people with confirmed H. pylori who have stomach symptoms.
SohagAges 18–75 - NCT07054307RecruitingPhase 1
Study of MRG003 plus HX008 for EGFR-positive penile cancer
This trial tests two drugs, MRG003 and HX008, as a first treatment for men with EGFR-positive penile squamous cell carcinoma that cannot be removed by surgery or has spread. The goal is to see if the combination shrinks tumors or delays growth.
Chengdu, SichuanAges 18 years+ - NCT07052604Recruiting
Antibiotic treatment for a rare pneumonia in ICU patients
This study looks at how well antibiotics work for pneumonia caused by a specific bacterium (Stenotrophomonas maltophilia) in patients who are on breathing machines in the intensive care unit (ICU). It will help doctors choose the best treatment.
Saint-Denis, FranceAges 18 years+ - NCT07050186RecruitingPhase 2
Cemiplimab for advanced NUT carcinoma
This trial tests a drug called cemiplimab for people with NUT carcinoma that has spread or cannot be removed. The drug aims to shrink tumors or slow their growth.
Chicago, IllinoisAges 18 years+ - NCT07054229Recruiting
Microwave ablation for low-risk thyroid microcancer
This study looks at whether microwave ablation, a minimally invasive treatment, works as well as surgery for small, low-risk thyroid cancers. It uses special ultrasound and genetic tests to help decide the best treatment.
Guangzhou, GuangdongAges 18–70 - NCT07054463Recruiting
Fu's needling for healing wrist fractures
This study tests whether adding Fu's subcutaneous needling (a special needle technique) to standard care (splinting after a bone realignment) helps heal wrist fractures faster. It's for adults who recently broke their wrist and have already had the bone set without surgery.
Guangzhou, GuangdongAges 18–85 - NCT07044830Recruiting
Sleep apnea treatment for stroke recovery
This trial tests whether treating sleep apnea with a CPAP machine soon after a stroke can improve recovery. It is for people who had their first moderate-to-severe ischemic stroke and have not used CPAP before.
Ribeirão Preto, São PauloAges 18–80
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,322 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.